Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CLPT
CLPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLPT News
ClearPoint Neuro (CLPT) Receives EU MDR Certification for Enhanced Navigation Software Version 3.0.2
Jan 23 2026
Benzinga
Booz Allen Hamilton Q3 Earnings Beat Estimates, Shares Up 9.8%
Jan 23 2026
Benzinga
Cementos Pacasmayo, Rezolve AI, Emerald Holding, and Other Major Stocks Rising on Monday
Dec 16 2025
Benzinga
Post-Market Winners: Biotech and Med-Tech Stocks Rise on FDA Developments, Trial Clarity, and Merger Momentum
Dec 16 2025
NASDAQ.COM
ClearPoint Neuro, Inc. Reports GAAP EPS of -$0.21, Falling Short by $0.01; Revenue of $8.86M Misses Expectations by $0.74M
Nov 06 2025
SeekingAlpha
Major Stocks, Including Kimberly-Clark and Vertex, Decline in Monday's Pre-Market Trading
Nov 03 2025
Benzinga
Friday's Major Stock Market Highlights: Morning News Summary!
Oct 03 2025
TipRanks
What’s Driving the Increase in ClearPoint Neuro Stock (CLPT) Today?
Oct 03 2025
TipRanks
ClearPoint Neuro Appoints Paul Larson as Chief Medical Officer
Sep 25 2025
Yahoo Finance
PepGen Shares Surge 112%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 25 2025
Benzinga
UniQure (QURE) Shares Surge 248% Following Huntington's Trial Outcomes; Analysts Adjust Price Targets Upward
Sep 25 2025
TipRanks
IMRX Rises on Pancreatic Cancer Findings, PEPG Achieves DM1 Splicing Correction Milestone, CLPT Under Observation
Sep 25 2025
NASDAQ.COM
"Discover the reasons behind UniQure's stock surge and its positive impact on ClearPoint shares."
Sep 24 2025
MarketWatch
ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript
Aug 13 2025
Newsfilter
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Aug 12 2025
NASDAQ.COM
Insider Sale: Director at $CLPT Sells 10,000 Shares
Jun 13 2025
NASDAQ.COM
Show More News
